Silk Therapeutics Garners $2,000,000 Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=18e06693-5888-4927-81ce-cbcf716a6fdc - Date
3/26/2015 - Company Name
Silk Therapeutics - Mailing Address
196 Boston Ave. Medford, MA 02155 USA - Company Description
The founders of Silk Therapeutics are world-renowned for pioneering silk science to improve human health. Dr. Greg Altman (CEO) and Dr. Rebecca Horan (COO) have worked together for more than 15 years developing silk-based applications, and now addressing unmet needs in skincare. - Website
http://www.silktherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$2,000,000 - Transaction Round
Series A - Proceeds Purposes
Silk Therapeutics will apply this new capital to support the launch of its clean, luxurious skincare line with initial rollout in the northeast and expanded efforts nationally, as well as to market the company’s professional line to the med-derm and spa communities. - M&A Terms
- Venture Investor
